Literature DB >> 16023541

Churg-Strauss syndrome presenting with subarachnoid hemorrhage from ruptured dissecting aneurysm of the intracranial vertebral artery.

Shigeyuki Sakamoto1, Shinji Ohba, Kuniki Eguchi, Masaaki Shibukawa, Yoshihiro Kiura, Takahito Okazaki, Yohsuke Kajihara, Kazunori Arita, Kaoru Kurisu.   

Abstract

Churg-Strauss syndrome (CSS) represents a rare systemic vasculitis that is almost invariably accompanied by bronchial asthma and eosinophilia. We report a case of a 36-year-old woman with previously diagnosed CSS presented with subarachnoid hemorrhage (SAH) from dissecting aneurysm in a vertebral artery (VA). Two months before onset of SAH, the patient had presented with numbness on her right lower leg due to peripheral neuropathy. On admission, angiography revealed dissecting aneurysm of the right intracranial VA and stenosis of the basilar artery. Hematological examination revealed an increased percentage of eosinophils. Ruptured dissecting aneurysm of the intracranial VA was diagnosed. Emergent coil embolization of the dissecting aneurysm and occlusion of the parent artery was performed to prevent repeated hemorrhage from the dissecting aneurysm. Then pharmacotherapy with prednisone was initiated for CSS. The patient recovered well and was discharged without any neurological deficit. As far as we know, this is the first reported case of CSS presented with SAH from dissecting aneurysm on posterior circulation.

Entities:  

Mesh:

Year:  2005        PMID: 16023541     DOI: 10.1016/j.clineuro.2004.09.020

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  8 in total

1.  Subarachnoid haemorrhage as the first clinical manifestation of Churg-Strauss syndrome.

Authors:  Una-Marie Sheerin; Julio Barreto; Martin M Brown; Stefan Brew; Nicholas A Losseff
Journal:  J Neurol       Date:  2008-03-20       Impact factor: 4.849

2.  Subarachnoid haemorrhage as the first clinical manifestation of Churg-Strauss syndrome.

Authors:  U-M Sheerin; J Barreto; M M Brown; S Brew; N A Losseff
Journal:  J Neurol       Date:  2008-05       Impact factor: 4.849

Review 3.  Eosinophilic granulomatosis with polyangiitis complicated by subarachnoid hemorrhage and coronary vasculitis: a case report and review of the literature.

Authors:  Shogo Matsuda; Shuzo Yoshida; Youhei Fujiki; Hidetoshi Satomi; Tohru Takeuchi; Yoshinobu Hirose; Shigeki Makino; Shigeki Arawaka
Journal:  Rheumatol Int       Date:  2017-11-10       Impact factor: 2.631

4.  Magnetic Resonance Thermometry-Guided Stereotactic Laser Ablation of Cavernous Malformations in Drug-Resistant Epilepsy: Imaging and Clinical Results.

Authors:  D Jay McCracken; Jon T Willie; Brad A Fernald; Amit M Saindane; Daniel L Drane; Daniel L Barrow; Robert E Gross
Journal:  Oper Neurosurg (Hagerstown)       Date:  2015-09-25       Impact factor: 2.703

5.  Spinal hematoma complicating a Churg-Strauss syndrome patient: a previously unreported association.

Authors:  Camila Cristina Kukita; Andre Luiz Nunes Gobatto; Alice Zoghbi Lobo; Leandro Utino Taniguchi
Journal:  Clinics (Sao Paulo)       Date:  2012-07       Impact factor: 2.365

6.  Flow diverter therapy for immunosuppressant-resistant vertebral artery fusiform aneurysm due to eosinophilic granulomatosis with polyangiitis: illustrative case.

Authors:  Tetsuya Hayashi; Hiroyuki Sakata; Masayuki Ezura; Atsushi Saito; Yoshinari Osada; Teiji Tominaga
Journal:  J Neurosurg Case Lessons       Date:  2022-03-14

Review 7.  Relapsing subarachnoid hemorrhage as a clinical manifestation in microscopic polyangiitis: a case report and literature review.

Authors:  Jingjing Xie; Ertao Jia; Suli Wang; Ye Yu; Zhiling Li; Jianyong Zhang; Jia Li
Journal:  Clin Rheumatol       Date:  2022-06-11       Impact factor: 3.650

8.  Subarachnoid and intracerebral hemorrhage in patients with churg-strauss syndrome: two case reports.

Authors:  Myeong Hoon Go; Jeong Un Park; Jae Gyu Kang; Yong Cheol Lim
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2012-09-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.